Audited Results of AstraZeneca Pharma India Ltd. Company

(Rs in Cr.) Mar 31, 2026 Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Operating Income 2,275.58 1,716.29 1,295.53 1,002.97 805.60
Manufacturing Expenses 0 5.30 4.87 5.54 8.10
Personnel Expenses 264.38 257.44 241.45 259.10 230.21
Selling Expenses 116 0 0 0 0
Administrative Expenses 252.63 233.93 267.99 210.79 166.04
Expenses Capitalised 0 0 0 0 0
Cost Of Sales 2,013.55 1,462.32 1,111.08 837.85 719.42
Operating Profit 262.03 253.97 184.45 165.12 86.18
Other Recurring Income 28.49 40.63 34.80 26.10 14.76
Adjusted PBDIT 290.52 294.60 219.25 191.22 100.94
Financial Expenses 4.49 1.46 1.20 0.63 0.95
Depreciation 28.58 39.99 14.94 16.26 16.95
Other Write offs 0 0 0 0 0
Adjusted PBT 257.45 253.15 203.11 174.33 83.04
Tax Charges 64.68 40.62 58.03 34.81 21.44
Adjusted PAT 192.77 212.53 145.08 139.52 61.60
Non Recurring Items -5.25 -97.96 17.43 -42.84 -1.74
Other Non Cash adjustments 0 0 0 0 0
Reported Net Profit 187.52 115.74 161.51 99.29 61.60
Equity Dividend 0 60 40 20 5
Preference Dividend 0 0 0 0 0
Retained Earnings 187.52 632.72 578.15 455.64 378.96

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+